Skip to content

Efficacy study of the consumption of milk fortified in vitamins and minerals

Efficiency study of iodine fortification of milk on iodine status markers: A longitudinal interventional non randomized, controlled study among school children in Morocco

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201410000896410
Enrollment
200
Registered
2014-09-29
Start date
2012-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Micronutrient deficiencies

Interventions

Efficiency study of multiple micronutrients fortification of milk on nutritional status

Sponsors

Ibn Tofail University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To be included in the study, children had to be aged between 7 and 9 years and should not take supplements during the study period

Exclusion criteria

Exclusion criteria: Children with severe malnutrition needing nutritional rehabilitation, or having chronic or severe illness requiring hospitalization or treatment were excluded from the study

Design outcomes

Primary

MeasureTime frame
Data analysis clearly demonstrated the amelioration of iodine status in fortified and non-fortified milk groups. Severe and mild iodine deficiencies were reduced for both groups. Moreover, there¿s complete disappearance of severe deficient cases in the fortified milk group after 4 months of intervention.; The prevalence of vitamin A deficiency for the fortified group dropped from 50% at baseline to 4.3% at end line compared to non-fortified group where it dropped from 44% to 24.8%. The difference between both groups was highly significant (p<0.0001).;Results of the fortified group showed that the prevalence of iron deficiency anemia (IDA) dropped from 1.8% at baseline to 0% at endline and prevalence of iron deficiency (ID) dropped significantly from 50.9% to 37.2% (p=0.037) compared to the non-fortified group where prevalences remained stable for both IDA and ID.

Secondary

MeasureTime frame
ongoing

Countries

Morocco

Contacts

Public ContactHassan AGUENAOU

Ibn Tofail University

aguenaou2014@gmail.com+212-663756730

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026